icon-folder.gif   Conference Reports for NATAP  
 
  ICAAC 2014 54th Interscience Conference
on Antimicrobial Agents and Chemotherapy
September 5-9, 2014, Washington, DC
Back grey_arrow_rt.gif
 
 
 
HIV NRTI BMS-986001 in Antiretroviral-Na´ve Subjects: Week 24/48 Analyses
 
 
  Reported by Jules Levin
ICAAC 2014 Sept 5-9 Wash DC
 
SK Gupta,1 J Lombaard,2 J Echevarria,3 C Orrell,4 A Avihingsanon,5 M Santoscoy,6 D Stock,7 SR Joshi,7 GJ Hanna,8 M Lataillade,7 for the AI467003 study team 1Indiana University School of Medicine, Indianapolis, IN, USA; 2. JOSHA Research, Bloemfontein Free State, South Africa; 3. Hospital Nacional Cayetano Heredia, Lima, Peru; 4. Desmond Tutu HIV Foundation, Cape Town, South Africa; 5. HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand; 6. Centro Glucomedi, DF, Mexico; 7. Bristol-Myers Squibb, Wallingford, CT, USA; 8. Bristol-Myers Squibb, Princeton, NJ, USA.

HCV1.gif

HCV2.gif

HCV3.gif

HCV4.gif

HCV5.gif

HCV6.gif

HCV7.gif

HCV8.gif

HCV9.gif

HCV10.gif

HCV11.gif